Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma

NCT01358045 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Basal Cell Carcinoma

Interventions

DRUG: Diclofenac
DRUG: Diclofenac + Calcitriol
DRUG: Calcitriol

Sponsor

Maastricht University Medical Center